ArticleCancer gene therapy2023

Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy.

Xisong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.